Fjeldbo, C. S., Hompland, T., Hillestad, T., Aarnes, E., Günther, C., Kristensen, G. B., . . . Lyng, H. (2020). Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity. EBioMedicine.
シカゴスタイル引用形Fjeldbo, Christina S., Tord Hompland, Tiril Hillestad, Eva-Katrine Aarnes, Clara-Cecilie Günther, Gunnar B. Kristensen, Eirik Malinen, , Heidi Lyng. "Combining Imaging- and Gene-based Hypoxia Biomarkers in Cervical Cancer Improves Prediction of Chemoradiotherapy Failure Independent of Intratumour Heterogeneity." EBioMedicine 2020.
MLA引用形式Fjeldbo, Christina S., et al. "Combining Imaging- and Gene-based Hypoxia Biomarkers in Cervical Cancer Improves Prediction of Chemoradiotherapy Failure Independent of Intratumour Heterogeneity." EBioMedicine 2020.